Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience

• Glavni autori: Lauren E. Brownell (Autor), Meagan L. Adamsick (Autor), Erin K. McCreary (Autor), Joshua P. Vanderloo (Autor), Erika J. Ernst (Autor), Emily R. Jackson (Autor), Lucas T Schulz (Autor)
• Format: Knjiga
• Izdano: Adis, Springer Healthcare, 2020-06-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Abstract Background Vancomycin treatment of complicated Gram-positive infections is associated with laboratory monitoring, nephrotoxicity, and multiple daily dosing. Oritavancin, a lipoglycopeptide antibiotic with a once-weekly dosing strategy and similar but slightly broader spectrum of activity, p...